Navigation Links
Martek Announces Fourth Quarter and FY 2009 Financial Results
Date:12/16/2009

ommission, including, but not limited to, Part I, Item 1A of the Company's Form 10-K for the fiscal year ended October 31, 2008 and other filed reports on Form 10-K, Form 10-Q and Form 8-K.

About Martek

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit www.martek.com.



                             MARTEK BIOSCIENCES CORPORATION
                       Summary Consolidated Financial Information
                  (Unaudited - $ in thousands, except per share data)

    Unaudited Condensed Consolidated Statements of Income Data

                                   Three months ended         Year ended
                                   ------------------       ---------------
                                       October 31,            October 31,
                                     2009       2008        2009       2008
                                     ----       ----        ----       ----

    Revenues:
      Product sales                $81,917    $86,644    $329,135   $336,609
      Contract manufacturing
       and services                  5,672      3,708      16,062     15,753
                                     -----      -----      ------     ------
        Total r
'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Martek Signs Sole-Source Supply Agreement with Fonterra
2. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
3. Martek Announces Addition to Its Board of Directors
4. Martek to Present at Two Upcoming Investor Conferences
5. Martek Announces Settlement of Patent Dispute with Capsugel France
6. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
7. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
8. Martek to Announce Third Quarter 2009 Results
9. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
10. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
11. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Veolia’s ... an exclusive North American distribution agreement with VWR ... system. , With more than 160 years of ... and services for laboratory and production facilities, has ... excellence and differentiated services to enable science. ...
(Date:5/20/2015)... , May 20, 2015 Veracyte, ... preliminary data demonstrating the ability of the company,s ... (IPF) from other interstitial lung diseases (ILDs) using ... classifier,s potential to help thousands of patients avoid ... in IPF diagnosis – a frequent challenge for ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
... designed for optimal image clarity , Eagle Eye ... Jane Moores ,Stratagene , A new optical filter has ... ,II Still Video System that increases contrast and sensitivity when ... II Still Video System,is currently sold with an optical ...
... mutations in any tissue with the Big Blue ... Boer Barry W. Glickman ,Centre for Environmental Health, ... Big Blue transgenic rodent mutation,assay,* which ... integrated shuttle vector, it is easy to study mutations ...
... A proven choice , , Matt ... transfection reagent offers,improved, consistent transfections for ... this article, we summarize the results of several ... transfection,conditions is a critical, preliminary step to achieving ...
Cached Biology Technology:Eagle Eye Optical Filter Optimized for Imaging Silver-Stained,Gels 2Eagle Eye Optical Filter Optimized for Imaging Silver-Stained,Gels 3Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 2Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 3Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 4Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 5Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 6Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 7Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 2Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 3Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 4Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 5Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 6Versatile Transfection Reagent Offers Low Toxicity and Consistent,Performance 7
(Date:4/27/2015)... 27, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... customers the first week of May, 2015 and will ... May. Gino Pereira , Chief ... the company as Wocket® enters the consumer market. We ...
(Date:4/21/2015)... Canada , April 21, 2015 ... and evolving government policies are boosting access control systems ... According to a recently published report by ... Opportunities, 2020 ", the access control systems market in ... nearly USD1.2 billion by 2020.The access control systems market ...
(Date:4/20/2015)... , April 20, 2015 ...   Glenbeigh Records Management (GRM), Ireland,s ... with Dubai Islamic Bank. Having built up an impressive track ... now a leading player within the records management sector in ... expects to double is GCC staffbase and employ a further ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... Scientists believe they have found an explanation for a ... , Researchers at Washington University School of Medicine in ... Nile virus can enter a nerve cell, replicate and ... traveling this infectious pathway can break into the central ...
... all its forms, but not all water in our life systems ... a cup of tea is different from the water in our ... have a complete understanding as to why intracellular water is different ... conflicting theories. The very structure of water, as an open system ...
... are wildly unfavorable environments. Struggling for oxygen and ... systems, tumor cells in fact require sophisticated adaptations ... sought ways to circumvent these adaptations to destroy ... Medical School (UMMS), have defined a method to ...
Cached Biology News:West Nile virus' spread through nerve cells linked to serious complication 2West Nile virus' spread through nerve cells linked to serious complication 3Let's talk -- new paradigms in the research of the biomolecular composition of water 2Sidestepping cancer's chaperone 2
UBN-1 (C-20)...
P2A4...
pETDuet-1 is designed for the coexpression of two target genes....
... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
Biology Products: